Real-world data can guide decisions about which patients should receive immunotherapy – Healio
|
Real-world data can guide decisions about which patients should receive immunotherapy
Healio NEW YORK — The pool of patients eligible to receive immunotherapy likely should include many individuals who were excluded from early immunotherapy trials, according to a presenter at HemOnc Today New York. “We need data from the real world,” Philip … |
